In the specialized field of pharmaceutical chemistry, sourcing high-purity compounds is paramount. Omeprazole N-Oxide, bearing the CAS number 176219-04-8, stands out as a critical molecule for researchers and chemical manufacturers. This compound, known for its role as an Omeprazole metabolite and its utility as a fine chemical intermediate, demands consistent quality and reliable availability.

Omeprazole N-Oxide is a chemically defined substance that serves multiple purposes in scientific endeavors. As a metabolite of the well-known proton pump inhibitor Omeprazole, it is indispensable for studies focusing on drug metabolism, pharmacokinetics, and analytical method development. Researchers often need this compound as a reference standard to accurately identify and quantify its presence in biological samples, thereby contributing to a deeper understanding of drug behavior in the body.

Furthermore, for chemical synthesis professionals, CAS 176219-04-8 represents a valuable intermediate. Its unique chemical structure allows it to be used as a building block in the creation of more complex molecules, potentially leading to new pharmaceutical agents or specialized chemical products. The purity of the sourced material directly impacts the success of these synthetic routes. Companies like NINGBO INNO PHARMCHEM CO.,LTD., a dedicated supplier from China, focus on providing Omeprazole N-Oxide that meets stringent purity specifications, ensuring its suitability for demanding synthesis applications.

The consistent supply of Omeprazole N-Oxide is also a critical factor for ongoing research projects and manufacturing processes. By partnering with reliable suppliers, research institutions and chemical companies can ensure that their supply chains remain robust. The commitment to quality, coupled with efficient logistics, makes NINGBO INNO PHARMCHEM CO.,LTD. a key partner for sourcing this important chemical. Whether for laboratory research or larger-scale synthesis, ensuring the availability of pure Omeprazole N-Oxide (CAS 176219-04-8) is a strategic advantage in the competitive landscape of pharmaceutical and chemical development.